Web analytics has traditionally been built around two central ideas:
- collect as much behavioural data as possible and
- connect everything together.
For e-commerce companies, SaaS businesses, and media sites, this logic has become the gold standard. The more granular the data, the better the attribution models, personalisation, audience segmentation, and conversion optimisation.
Healthcare and pharmacy environments completely change the equation.
A person visiting a healthcare website is not just another “user.”
Their browsing behaviour may reveal deeply personal information about physical health, mental health, medication use, fertility, addiction recovery, chronic illness, or sexual health.
In most online situations, visitors never explicitly share this information. The sensitive profile emerges indirectly from context.
The same is true for people visiting marketing web sites of pharmaceutical products, online pharmacies or drugstores. Any page view can potentially be used for inferring information regarding visitor’s health.
This is where the traditional digital analytics approach becomes problematic.
Healthcare website analytics can reveal sensitive personal data
Consider this visitor path:
- A visitor reads content about depression.
- The same browser visits a product page for antidepressants.
- An unnamed product is then added to the shopping cart.
- Finally, a purchase is completed on a page that includes the customer’s name and email address.
At first glance, the collected analytics data may look harmless. Perhaps the shopping cart event contains no product names. Perhaps the analytics platform only stores pseudonymous identifiers, and hashed name and email are not used for stitching user journeys.
But the risk rarely comes from a single field in isolation.
The real risk emerges from combinations.
Page metadata, URLs, content categories, timestamps, client IDs, session IDs, IP addresses, geolocation, browsing sequences, ecommerce behaviour, and booking flows can together create highly sensitive inferred profiles. Even when explicit medical information is never collected, behavioural context may strongly imply a health condition, treatment interest, or medication use.
This is one reason why healthcare web analytics deserves its own discussion. We cannot simply apply generic best practices to a more regulated industry.
URL structures and page metadata create privacy risks in healthcare
The privacy risk does not begin with analytics tools alone. In many healthcare environments, the website structure itself may already expose sensitive information.
Healthcare websites often use descriptive and search-engine-friendly URLs. From a usability and SEO perspective, structures like /depression-treatment/, /ivf-booking/, or /adhd-assessment/ make perfect sense.
Unfortunately, URLs are visible to many different systems.
Browsers, browser history, browser extensions, operating systems, security software, network infrastructure, referrer headers, proxies, and third-party scripts may all observe this information.
This means sensitive exposure may occur even when web analytics and advertising tracking is minimal or absent. For data protection authorities, this kind of technical architecture increasingly matters because they consider inference risk and linkability.
The question is no longer only whether an organisation stores names or email addresses in GA4. The more difficult question is whether multiple weak signals can be combined into sensitive conclusions about an individual.
Healthcare websites are especially vulnerable to this problem because their traffic volumes are often lower and their user journeys are very specific. A small number of behavioural signals may already narrow the possible identity or medical context of a visitor considerably.
Privacy-first web analytics reduces risk
Healthcare organisations still need digital analytics. They need to understand whether
- Informational content helps patients,
- booking flows work properly,
- pharmacy e-commerce journeys are usable, etc.
But many standard analytics methods become difficult once we minimise sensitive metadata, avoid persistent identifiers, mask shopping cart data, and limit URL exposure.
- Measuring content performance becomes more difficult when healthcare topics cannot appear safely in URLs, page metadata, or analytics events.
- Attribution becomes weaker if informational browsing cannot be safely linked to appointment bookings.
- E-commerce optimisation becomes less granular if pharmacy products cannot be analysed at the SKU level.
From a marketer’s perspective, this feels frustrating. The analytics industry has spent years moving toward increasingly detailed user-level tracking, identity stitching, and cross-platform profiling. Healthcare environments often require movement in the opposite direction.
In practice, this may mean intentionally reducing linkability between events. Organisations may need to shorten retention periods, rotate identifiers more frequently, limit geolocation precision, avoid persistent cross-session IDs, and minimise metadata collection.
Server-side tracking for healthcare analytics should focus on data minimisation
Server-side tracking is frequently marketed as a way to improve data quality and quantity in a world of ad-blockers and privacy-focused browsers.
In healthcare environments, its primary role is data minimisation and redaction.
A properly designed server-side layer allows organisations to remove sensitive information before it reaches analytics vendors, advertising platforms, or other external systems.
URLs can be sanitised, query parameters removed, product names stripped, search terms filtered, and identifiers minimised.
Technologies such as JENTIS, server-side Google Tag Manager, reverse proxies, and custom collection endpoints can support this kind of architecture.
However, server-side tracking itself is not automatically privacy-friendly. A poorly designed server-side implementation just centralises the collection of highly sensitive data.
The privacy benefit only appears if the organisation uses the architecture to minimise outgoing data and avoid exposure to third parties.
In practice, healthcare organisations should carefully evaluate whether the following data should be removed, masked, generalised, or never collected at all:
- healthcare-related URL paths
- page titles containing medical terminology
- search queries
- product names and SKUs
- booking reason descriptions
- free-text form fields
- persistent client identifiers
- long-lived session identifiers
- exact timestamps
- geographic location
- referrer URLs
- user-agent level fingerprinting signals
- IP addresses
- advertising click identifiers
- cross-device identifiers
Another important safeguard concerns advertising and marketing, trackers.
In healthcare websites, URLs and titles themselves may contain highly sensitive information. Treatment names, medication references, mental health topics, fertility services, diagnostic information, and booking intent can all become visible through page metadata alone.
Sending this information directly to advertising platforms may allow external systems to infer highly sensitive health-related interests or conditions.
Organisations should therefore consider removing URLs entirely from advertising payloads, hashing page paths and titles, mapping sensitive pages into generic categories, blocking tracking from highly sensitive sections, removing referrer information, and limiting metadata shared with third parties.
Importantly, hashing alone is not always sufficient protection. If the underlying set of URLs or page titles is predictable or limited, hashes are often reversible through dictionary-style matching. This is especially relevant for healthcare websites with clearly named treatment or medication pages.
In practice, complete removal or aggressive categorisation of sensitive metadata is often the safest solution.
On-premises web analytics and EU hosting reduce healthcare privacy risks
For healthcare organisations, infrastructure choices matter.
Keeping analytics infrastructure within the EU, or operating analytics on-premises, deserves serious consideration.
When highly sensitive browsing behaviour remains within the organisation’s controlled environment, the risk profile differs from transmitting raw behavioural data to external analytics vendors.
In many healthcare scenarios, on-premises analytics (Matomo Analytics, for example) may be the safer option precisely because special category personal data is not disclosed to an external analytics processor.
This is one reason why self-hosted analytics solutions continue to attract interest in highly regulated industries.
In practice, many healthcare businesses use Piwik PRO as it provides a good balance between marketing needs and privacy especially in combination with a serverside tag management solution.
Online pharmacy and drugstore web analytics creates special privacy challenges
Traditional e-commerce analytics relies heavily on product-level detail.
In pharmacies, products themselves may reveal medical conditions, treatments, or private life situations. Even broad ecommerce datasets may become highly sensitive when connected with browsing history, timestamps, location data, and persistent identifiers.
As a result, healthcare and pharmacy analytics may increasingly move toward aggregated models.
Instead of maximising user-level attribution, organisations may need to settle for broader category-level insights, modelled reporting, contextual analysis, shorter attribution windows, and anonymous ecommerce funnels.
This reduces analytical precision, but it also limits the risk of creating sensitive health-related behavioural profiles.
Media mix modelling offers a privacy-friendly alternative to cookie-based attribution
Healthcare marketing teams still need to understand whether advertising investments generate results.
The problem is that traditional attribution models often depend heavily on cookies, persistent identifiers, user-level journeys, cross-session tracking, and advertising platform integrations.
In healthcare environments, these approaches create privacy risks.
This is one reason why media mix modelling deserves renewed attention.
Instead of tracking individual users across channels and devices, media mix modelling analyses aggregated relationships between media investments, traffic, bookings, revenue, seasonal trends, and external factors.
The goal is not to identify which individual user converted after seeing an advertisement. The goal is to estimate which marketing activities contribute to business outcomes at an aggregated level.
For healthcare organisations, this approach may be far more compatible with privacy-first principles.
Media mix modelling can help organisations reduce their reliance on cookies, avoid cross-platform user tracking, minimise the use of persistent identifiers, decrease reliance on invasive attribution methods, and evaluate long-term marketing effectiveness.
But healthcare organisations may increasingly need to accept that privacy-safe measurement requires more statistical modelling and less individual surveillance.
The future of healthcare analytics is privacy-first measurement
That does not mean web analytics become useless. Healthcare organisations can still improve patient journeys, optimise digital services, understand operational bottlenecks, and evaluate content effectiveness.
Healthcare has already become one of the industries driving digital analytics in a new direction: privacy engineering, aggregation, and controlled uncertainty.
That transition will not always be comfortable for analysts or digital marketers.
But it will produce systems that are more sustainable, more trustworthy, and more compatible with customer expectations.